Scanning Flow Cell

Oxford Nanopore Technology Update Shows Consolidations and Updates for a Single, High-performance Sequencing Platform

Retrieved on: 
Wednesday, December 7, 2022
Health, Technology, Genetics, Software, Research, Science, Biotechnology, Dorado, London Calling, Genome, Chemistry, Virus, Simplex, Enzyme, Turbot, Ecosystem, Plant, Software, Scanning Flow Cell, Duplex, Bacteria, DNA, Cancer, Animal, Research, Biology, Methylation, Next, SNV, Oxford Nanopore Technologies, Molecular biology, Cell, Data analysis, Genomics, Human, Whole genome sequencing, Oxford, IPad, HAC, SNP, A100, Genetic variation, Metagenomics, Blood, Machine learning, RNA, Nanopore, Video game console, Fine chemical, Vaccine, Antibiotics, Mobile phone, GitHub

At the Nanopore Community Meeting, Rosemary Sinclair Dokos, Stuart Reid and Lakmal Jayasinghe showed how the Oxford Nanopore sequencing platforms capabilities continue to be pushed.

Key Points: 
  • At the Nanopore Community Meeting, Rosemary Sinclair Dokos, Stuart Reid and Lakmal Jayasinghe showed how the Oxford Nanopore sequencing platforms capabilities continue to be pushed.
  • Multiple updates and consolidations to improve and simplify the platform were presented, showcasing a single, simple, high-performance sequencing technology.
  • Updates were provided that included developments in platform chemistry, hardware, data analysis, preparation and product range:
    Oxford Nanopores sequencing platform provides a comprehensive view of human, and any other genomes, with simple, scalable workflows.
  • An open data analysis ecosystem has now been created, to combine user workflows with the Oxford Nanopore platform.

Oxford Nanopore Technologies Announces New Collaboration With 10x Genomics to Make Single-cell and Spatial Full-length Isoform Transcript Sequencing Accessible to Any Laboratory

Retrieved on: 
Thursday, October 27, 2022
Health, Technology, Other Technology, Genetics, Other Health, Biotechnology, Genomics, Cell biology, Embryonic development, Alternative splicing, Oxford Nanopore Technologies, Chromium, Spatial transcriptomics, Oxford, Scanning Flow Cell, DNA, CPP, Population, Genetics, Nanopore sequencing, Biology, Workflow, Nanopore, 10x Genomics, Research, Transcriptome, Atlas, USD, B cell, Antibiotics, Medical imaging

Oxford Nanopore Technologies plc (Oxford Nanopore) today announces a collaboration with 10x Genomics, to enable a streamlined workflow for sequencing full-length transcripts in single reads on highly accessible Oxford Nanopore devices.

Key Points: 
  • Oxford Nanopore Technologies plc (Oxford Nanopore) today announces a collaboration with 10x Genomics, to enable a streamlined workflow for sequencing full-length transcripts in single reads on highly accessible Oxford Nanopore devices.
  • The collaboration covers the addition of Oxford Nanopores PromethION devices and selected consumables, in conjunction with sample preparation on the 10x Genomics devices, into the 10x Genomics Compatible Partner Program (CPP).
  • Both parties believe this will enable a streamlined customer experience and highlight the compelling utility of nanopore-based sequencing in conjunction with 10x Genomics workflows.
  • Now, with Oxford Nanopore, 10x Genomics users can easily add a new dimension to their data using the fastest and most cost-effective full-length transcript sequencing approach.

Oxford Nanopore Opens Genomics Market With PromethION 2 Solo: The World’s First Portable, High Yield Sequencer Providing Comprehensive DNA Analysis for Anyone, Anywhere

Retrieved on: 
Monday, October 24, 2022
Data Management, Biotechnology, Technology, Professional Services, Health, Health Technology, Research, Data Analytics, Genetics, Science, Hardware, Infection, Molecular biology, Nanopore sequencing, Virus, Science, Workflow, Animal, Genomics, Oxford Nanopore Technologies, Biology, RNA, Nanopore, Research, Multimedia, Cancer, Ring, Technology, Plant, Phrase, Bacteria, P48, Genetics, GPU, Genome, Methylation, Running, DNA, Lord, Single-nucleotide polymorphism, Forward-looking statement, Human, View, Scanning Flow Cell, Antibiotics

Users can scale to ~ 4,600-9,200 human genomes per year with the PromethION 48 (P48).

Key Points: 
  • Users can scale to ~ 4,600-9,200 human genomes per year with the PromethION 48 (P48).
  • The P2 Solo device will further contribute to the ongoing democratisation of genomics research and expand scientific discovery using comprehensive nanopore data.
  • Oxford Nanopore Technologies goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere.
  • The company has developed a new generation of nanopore-based sensing technology for real-time, high-performance, accessible and scalable analysis of DNA and RNA.